Skip to main content

Modelling donor screening strategies to reduce the risk of SARS-CoV-2 transmission via fecal microbiota transplantation

Olesen, S., Zaman, A., Osman, M., & Ramakrishna, B. (2020). Modelling donor screening strategies to reduce the risk of SARS-CoV-2 transmission via fecal microbiota transplantation. Open Forum Infectious Diseases. doi: 10.1093/ofid/ofaa499

Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockade

SahBandar, I., Chew, G., Corley, M., Pang, A., Tsai, N., & Hanks, N. et al. (2020). Changes in gastrointestinal microbial communities influence HIV-specific CD8+ T-cell responsiveness to immune checkpoint blockade. AIDS, 34(10), 1451-1460. doi: 10.1097/qad.0000000000002557

Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study

Vendrik, K., Terveer, E., Kuijper, E., Nooij, S., Boeije-Koppenol, E., & Sanders, I. et al. (2020). Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort study. The Lancet Infectious Diseases. doi: 10.1016/s1473-3099(20)30473-4

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

Aroniadis, O., Brandt, L., Oneto, C., Feuerstadt, P., Sherman, A., & Wolkoff, A. et al. (2019). Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial. The Lancet Gastroenterology & Hepatology. doi:10.1016/s2468-1253(19)30198-0

Fulminant Clostridium difficile Infection Cured by Fecal Microbiota Transplantation in a Bone Marrow Transplant Recipient With Critical Neutropenia

Krajicek, E., Bohm, M., Sagi, S., & Fischer, M. (2019). Fulminant Clostridium difficile Infection Cured by Fecal Microbiota Transplantation in a Bone Marrow Transplant Recipient With Critical Neutropenia. ACG Case Reports Journal, 6(8), e00198. doi:10.14309/crj.0000000000000198

Successful Treatment of Fulminant Clostridioides difficile Infection with Emergent Fecal Microbiota Transplantation in a Patient with Acute Myeloid Leukemia and Prolonged, Severe Neutropenia

Lee, M., Ramakrishna, B., Moss, A., Gold, H., & Branch‐Elliman, W. (2019). Successful Treatment of Fulminant Clostridioides difficile Infection with Emergent Fecal Microbiota Transplantation in a Patient with Acute Myeloid Leukemia and Prolonged, Severe Neutropenia. Transplant Infectious Disease. doi:10.1111/tid.13216

Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study

Santiago, M., Eysenbach, L., Allegretti, J., Aroniadis, O., J. Brandt, L., & Fischer, M. et al. (2019). Microbiome predictors of dysbiosis and VRE decolonization in patients with recurrent C. difficile infections in a multi-center retrospective study. AIMS Microbiology, 5(1), 1-18. doi:10.3934/microbiol.2019.1.1

Intestinal Microbial and Metabolic Alterations Following Successful Fecal Microbiota Transplant for D-Lactic Acidosis

Bulik-Sullivan, E. C., Roy, S., Elliott, R. J., Kassam, Z., Lichtman, S. N., Carroll, I. M., & Gulati, A. S. (2018). Intestinal microbial and metabolic alterations following successful fecal microbiota transplant for D-lactic acidosis. Journal of Pediatric Gastroenterology and Nutrition, 67(4), 483-487.

HIV-exposure, early life feeding practices and delivery mode impacts on faecal bacterial profiles in a South African birth cohort

Claassen-Weitz, S., Gardner-Lubbe, S., Nicol, P., Botha, G., Mounaud, S., Shankar, J., … & Nicol, M. P. (2018). HIV-exposure, early life feeding practices and delivery mode impacts on faecal bacterial profiles in a South African birth cohort. Scientific Reports, 8(1), 5078.

Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort

Gurry, T., HST Microbiome Consortium*, Gibbons, S. M., Nguyen, L., Kearney, S. M., Ananthakrishnan, A., Jiang, X., Duvallet, C., Kassam, Z., … Alm, E. J. (2018). Predictability and persistence of prebiotic dietary supplementation in a healthy human cohort. Scientific Reports, 8(1), 12699. doi:10.1038/s41598-018-30783-1

Fecal Microbiota Transplantation Improves Gastrointestinal Graft-Versus-Host Disease and Restores the Microbiome: A Pediatric Experience

Wong, W. F., Budree, S., Osman, M., Panchal, P., Kassam, Z., Corkins, M. R., … & Maron, G. M. (2018). Tu1882-Fecal Microbiota Transplantation Improves Gastrointestinal Graft-Versus-Host Disease and Restores the Microbiome: A Pediatric Experience. Gastroenterology, 154(6), S-1046.

Serendipity in Refractory Celiac Disease: Full Recovery of Duodenal Villi and Clinical Symptoms after Fecal Microbiota Transfer

van Beurden, Y.H., van Gils, T., van Gils, N.A., Kassam, Z., Mulder, C.J., Aparicio-Pagés, N. (2016) Serendipity in Refractory Celiac Disease: Full Recovery of Duodenal Villi and Clinical Symptoms after Fecal Microbiota Transfer. J Gastrointestin Liver Dis., 25(3), 385-8.

Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in Humans

Bustamante JM, Dawson T, Loeffler C, Marfori Z, Marchesi JR, Mullish BH, Thompson CC, Crandall KA, Rahnavard A, Allegretti JR, Cummings BP. Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in Humans. Nutrients. 2022 Dec 7;14(24):5200. doi: 10.3390/nu14245200. PMID: 36558359; PMCID: PMC9785599.

Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation

Gulati AS, Nicholson MR, Khoruts A, Kahn SA. Fecal Microbiota Transplantation Across the Lifespan: Balancing Efficacy, Safety, and Innovation. Am J Gastroenterol. 2023 Jan 25. doi: 10.14309/ajg.0000000000002167. Epub ahead of print. PMID: 36580630.